Ilary Ruscito

Pubblicazioni

Titolo Pubblicato in Anno
Immunobiology of solid cancers: cellular and molecular pathways as potential diagnostic and therapeutic targets BIOMED RESEARCH INTERNATIONAL 2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway CANCER IMMUNOLOGY RESEARCH 2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis GYNECOLOGIC ONCOLOGY 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study) BRITISH JOURNAL OF CANCER 2018
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells FRONTIERS IN IMMUNOLOGY 2018
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium EUROPEAN JOURNAL OF CANCER 2017
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells FRONTIERS IN IMMUNOLOGY 2017
PI3K/AKT/mTOR pathway in ovarian cancer treatment: are we on the right track? GEBURTSHILFE UND FRAUENHEILKUNDE 2017
Beyond circulating microRNA biomarkers: urinary microRNAs in ovarian and breast cancer TUMOR BIOLOGY 2017
Genetic versus epigenetic BRCA1 silencing pathways: clinical effects in primary ovarian cancer patients. A study of the tumor bank ovarian cancer consortium INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2017
The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology Molecular Oncology: Underlying Mechanisms and Translational Advancements 2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients JOURNAL OF CLINICAL ONCOLOGY 2017
The efficacy of fibrin sealant patches in reducing the incidence of lymphatic morbidity after radical lymphadenectomy: A meta-analysis INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2017
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial INTERNATIONAL JOURNAL OF ONCOLOGY 2016
Cediranib in ovarian cancer. state of the art and future perspectives TUMOR BIOLOGY 2016
Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer TUMOR BIOLOGY 2016
Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes. A meta-analysis ANNALS OF SURGICAL ONCOLOGY 2016
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells ANTICANCER RESEARCH 2016
Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer ANNALS OF SURGICAL ONCOLOGY 2016
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium TUMOR BIOLOGY 2016

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma